Candriam S.C.A.

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1537014 STRASSEN, N4

Position in RYTM

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$40,383,649

+$9,566,084 QoQ

Shares Held

464,340

+61.3% QoQ

Ownership

0.678%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Candriam S.C.A. holds $1,920,933,361 across 79 Biotechnology names. RYTM ranks #13 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	186,388	$144,010,824
2	VRTX	Vertex Pharmaceuticals Inc / Ma	228,915	$102,219,704
3	ONC	BeOne Medicines Ltd.	259,731	$77,132,315
4	ALNY	Alnylam Pharmaceuticals, Inc.	224,330	$74,224,067
5	INSM	INSMED Inc	401,735	$65,691,707
6	COGT	Cogent Biosciences, Inc.	1,516,297	$58,362,271
7	RVMD	Revolution Medicines, Inc.	580,677	$56,470,838
8	ROIV	Roivant Sciences Ltd.	2,001,976	$55,454,735

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$40,383,649	464,340	+61.3%	Shares	Sole	2026-04-30
2025-12-31	$30,817,565	287,907	+29.8%	Shares	Sole	2026-04-30
2025-09-30	$22,405,944	221,863	-29.0%	Shares	Sole	2025-11-06
2025-06-30	$19,743,841	312,452	+7.2%	Shares	Sole	2025-08-08
2025-03-31	$15,439,112	291,469	-12.3%	Shares	Sole	2025-05-14
2024-12-31	$18,607,304	332,392	-15.9%	Shares	Sole	2025-02-07
2024-09-30	$20,713,801	395,377	+45.7%	Shares	Sole	2024-11-13
2024-06-30	$11,143,601	271,398	+735.6%	Shares	Sole	2024-08-05
2022-12-31	$945,788	32,479	-15.1%	Shares	Sole	2023-02-13
2022-09-30	$936,733	38,234	—	Shares	Sole	2022-11-10
No filing history on record for this holder in this stock.